![Humens logo](/sites/default/files/styles/etudes_thumbs/public/2024-02/logo_Humens.jpg?itok=Sr1RxrBZ)
Stories
Mid-large buyout
BMS is a dynamic global broker (7th Largest with more than 15% of organic growth) that provides specialist insurance, reinsurance and capital markets advisory services. BMS Group was formerly known as Ballantyne, Mckean & Sullivan Limited
Mid-large buyout
StatusIn portfolio
Investment date12/2022
SectorFinancial Services
LocationEurope
a regional data center operator
Infrastructure
StatusIn portfolio
Investment date02/2023
SectorTech-enabled
LocationEurope
TSE is a solar power producer in France
Infrastructure
StatusIn portfolio
Investment date05/2023
SectorTech-enabled
LocationEurope
Cloud-based e-commerce software focused on APIs and micro services for real omnichannel customer experiences.
Growth
StatusIn portfolio
Investment date06/2023
SectorTech-enabled
LocationEurope
2BSI is a materials and energy recovery specialist operating in niche markets
Infrastructure
StatusIn portfolio
Investment date07/2023
SectorTech-enabled
LocationEurope
Created in 1995 by Philippe Genne, Oncodesign is a biopharmaceutical company specialized in preclinical pharmacological evaluation of new cancer therapies on behalf of pharmaceutical and biotechnology companies
Healthcare - Nov Santé
StatusIn portfolio
Investment date12/2023
SectorHealthcare
LocationEurope
Eurazeo Investment Manager (EIM) and Eurazeo Mid Cap (EMC) are merging to form Eurazeo Global Investor (EGI)